熱門資訊> 正文
Affimed任命Shawn Leland为首席执行官
2024-09-03 19:58
- Affimed N.V. (NASDAQ:NASDAQ:NASDAQ:NASDAQ:AFMD) has announced that Shawn M. Leland, PharmD, RPh has been appointed as Chief Executive Officer (CEO).
- Dr. Andreas Harstrick, acting CEO since January 2024 will continue in his position as Chief Medical Officer (CMO).
- Most recently, Shawn was the Interim CEO and Board Director of ForeBio.
- Source: Press Release
More on Affimed
- Affimed N.V. (AFMD) Q1 2024 Earnings Call Transcript
- Affimed N.V. 2024 Q1 - Results - Earnings Call Presentation
- Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better
- Affimed says 86% of patients responded to lymphoma therapy in mid-stage trial
- Seeking Alpha’s Quant Rating on Affimed
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
